Speech in Westminster Hall - Mon 08 Sep 2014
Pancreatic Cancer
"Thank you, Mr Chope. It is good to serve under you, and we did hear the applause.
I congratulate my colleague the hon. Member for Scunthorpe (Nic Dakin) on such a brilliant start to the debate and I thank him for the support that he has given the all-party group …..."Eric Ollerenshaw - View Speech
View all Eric Ollerenshaw (Con - Lancaster and Fleetwood) contributions to the debate on: Pancreatic Cancer
Speech in Westminster Hall - Mon 08 Sep 2014
Pancreatic Cancer
"I thank the hon. Gentleman for underlining that critical point about survival rates and their impact on the ability of researchers to get that much-needed research.
The consensus we found was that more work is needed and that one of the reasons why survival rates for other cancers are increasing …..."Eric Ollerenshaw - View Speech
View all Eric Ollerenshaw (Con - Lancaster and Fleetwood) contributions to the debate on: Pancreatic Cancer
Speech in Westminster Hall - Mon 08 Sep 2014
Pancreatic Cancer
"The hon. Lady makes an extremely important point, which the all-party group was trying to weigh up. The hon. Member for Scunthorpe made an important point about CT scans and made the important suggestion that there should be pilots. Also, interestingly, he mentioned that the going backwards and forwards between …..."Eric Ollerenshaw - View Speech
View all Eric Ollerenshaw (Con - Lancaster and Fleetwood) contributions to the debate on: Pancreatic Cancer
Speech in Westminster Hall - Mon 08 Sep 2014
Pancreatic Cancer
"I am grateful for that intervention, particularly as I will go on to mention the Recalcitrant Cancer Research Act—as usual, my hon. Friend has got in before me. He is on exactly the right lines in terms of what we are all thinking.
I have talked about good news and …..."Eric Ollerenshaw - View Speech
View all Eric Ollerenshaw (Con - Lancaster and Fleetwood) contributions to the debate on: Pancreatic Cancer
Speech in Westminster Hall - Mon 08 Sep 2014
Pancreatic Cancer
"My hon. Friend makes an important point. It is difficult for Ministers and boards to make decisions about what is or is not fashionable. Nothing we are trying to do, in getting pancreatic cancer higher up the agenda, is aimed at taking away from the advances being made for other …..."Eric Ollerenshaw - View Speech
View all Eric Ollerenshaw (Con - Lancaster and Fleetwood) contributions to the debate on: Pancreatic Cancer
Speech in Westminster Hall - Mon 08 Sep 2014
Pancreatic Cancer
"I thank the hon. Gentleman for that. I think everybody here—all the people who signed the e-petition and the hon. Members who are here to support the debate—realises that it will be a fairly long journey. We are trying to say that we want a quicker start to that journey, …..."Eric Ollerenshaw - View Speech
View all Eric Ollerenshaw (Con - Lancaster and Fleetwood) contributions to the debate on: Pancreatic Cancer
Speech in Westminster Hall - Mon 08 Sep 2014
Pancreatic Cancer
"I thank my hon. Friend. If raising awareness was the one thing to come from this petition, all of us who have been affected would say that was positive.
Thousands have signed the e-petition that we are debating because they believe the purpose of government is to make improvements in …..."Eric Ollerenshaw - View Speech
View all Eric Ollerenshaw (Con - Lancaster and Fleetwood) contributions to the debate on: Pancreatic Cancer
Written Question
Thursday 4th September 2014
Asked by:
Eric Ollerenshaw (Conservative - Lancaster and Fleetwood)
Question
to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps his Department has taken since 2009 to review policy on addiction to prescription medication; and what the total identifiable costs have been of this review process.
Answered by Jane Ellison
The Department has been reviewing policy on addiction to prescription medicine over this period, and the Government’s Drug Strategy, published in December 2010, highlights our commitment to reduce dependence on prescription and over the counter medicines.
In 2009, the Department identified a lack of information on this important subject. The Department commissioned a literature review from the National Addiction Centre and a report from the National Treatment Agency for Substance Misuse (NTA) which interrogated data on specialist treatment and surveyed local commissioners and specialist treatment providers. These reports were peer reviewed and published in May 2011. The cost to the Department for the National Addiction Centre literature review was £9,750 and the cost for the NTA review was £80,000.
The reports informed the discussions of roundtable meetings of expert stakeholders which were convened by the Minister for Public Health to agree action to tackle addiction to medicines. The roundtable produced a consensus statement, endorsed by the Royal College of General Practitioners, the Royal College of Psychiatrists and other organisations which was published in January 2013. The only direct cost to the Department concerning the roundtables, and other meetings, was £1,928.09 in travel expenses for non-Departmental staff.
Other Departmental costs associated with reviewing policy on addiction to prescription medicine are not separately identifiable.
Public Health England (PHE) organised a seminar in February 2013 to improve the commissioning of services to treat addiction to medicine, and following the seminar, in June 2013 published a guide for the National Health Service and local authorities on commissioning treatment for dependence on prescription and over-the-counter medicines.
The Medicines and Healthcare products Regulatory Agency published in March 2013 a learning module on benzodiazepines which includes advice for prescribers on preventing and treating dependence on these medicines.
In July 2014, with the approval of the Department and the devolved administrations, PHE launched a public consultation on whether there should be an update to the 2007 United Kingdom clinical guidelines on drug misuse and dependence. The guidelines include advice on treating dependence on benzodiazepines.
Speech in Commons Chamber - Mon 01 Sep 2014
Clinical Technology Appraisals (NICE)
"I welcome the Minister to his place. I hope that he does not feel that he has drawn the short straw by having the 10 o’clock slot. I am pleased to be here to have the opportunity to raise an issue of growing concern to NHS patients throughout the country, …..."Eric Ollerenshaw - View Speech
View all Eric Ollerenshaw (Con - Lancaster and Fleetwood) contributions to the debate on: Clinical Technology Appraisals (NICE)
Speech in Commons Chamber - Wed 16 Jul 2014
Special Measures Regime
"With reference to University Hospitals of Morecambe Bay NHS Foundation Trust, which has just gone into special measures, may I reassure the Secretary of State that the CQC has seen some improvements there delivered by front-line staff, particularly at Royal Lancaster infirmary? However, I want to underline what the hon. …..."Eric Ollerenshaw - View Speech
View all Eric Ollerenshaw (Con - Lancaster and Fleetwood) contributions to the debate on: Special Measures Regime